Subscribe

Subscribe

Latest Content

Solar

Storage

Wind

Event Spotlight

BLOGS

DISTRIBUTECH+ RECAP: Energy Storage Utility Case Studies

Webcast

OPINION

RESOURCES

CLARION ENERGY MEDIA

POWER & ENERGY EVENT SERIES

Privacy Policy

Copyright © 2019 - 2021

Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hcw Biologics Inc (NQ: HCWB )

0.6130 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.6130
Bid (Size) 0.5000 (4)
Ask (Size) 0.8200 (1)
Prev. Close 0.6130
Today's Range 0.6130 - 0.6130
52wk Range 0.4000 - 2.166
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
HCWB Stock Earnings: HCW Biologics Reported Results for Q2 2024
HCW Biologics just reported results for the second quarter of 2024. 
Via InvestorPlace
HCWB Stock Earnings: HCW Biologics Reported Results for Q1 2024
HCW Biologics just reported results for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
-48.92%
-48.92%
1 Month
+30.43%
+30.43%
3 Month
-23.39%
-23.39%
6 Month
-64.15%
-64.15%
1 Year
-68.88%
-68.88%

More News

Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
HCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Looking Into HCW Biologics's Return On Capital Employed
Via Benzinga
Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
From HCW Biologics, Inc
Via GlobeNewswire
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting
From HCW Biologics, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023
From HCW Biologics, Inc
Via GlobeNewswire
Nerdy And 3 Other Stocks Under $4 Insiders Are Aggressively Buying
Via Benzinga
$3M Bet On This Technology Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
$25M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Recap: HCW Biologics Q1 Earnings
Via Benzinga
HCW Biologics: Q1 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan
From HCW Biologics, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why SeaChange International Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
HCW Biologics Enters CRADA with National Cancer Institute
From HCW Biologics, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Smith Micro Software And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.